Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Investigating B and CD4 T Cell Roles in Multiple Sclerosis

Official title: Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis

Run by University Hospital, Bordeaux · NCT04798651 · Data updated 2026-11-12

This study is trying to understand how certain immune cells affect multiple sclerosis in patients to help find better treatments.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorUniversity Hospital, Bordeaux
Academic / other
Locations1 site (Bordeaux)
StatusRecruiting
StartedSeptember 30, 2021
Main results expectedSeptember 2027
Study endsSeptember 2027
Registry record updatedOctober 26, 2026
Trial IDNCT04798651 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older diagnosed with multiple sclerosis or clinically isolated syndrome.

Probably not a fit

Patients who are pregnant, breastfeeding, or unable to provide consent due to legal restrictions will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to identify the pathogenic properties of B and CD4 T cell subsets in patients with multiple sclerosis (MS) and clinically isolated syndrome (CIS). By analyzing blood and cerebro-spinal fluid samples from 150 participants, the researchers will explore the immune mechanisms involved in different forms of MS. The goal is to enhance understanding of disease progression and potentially develop new therapeutic strategies. The study is conducted at Bordeaux University Hospital, focusing on the immune response in MS patients.

Why it matters

Potential benefit: If successful, this research could lead to new treatment options that more effectively halt the progression of multiple sclerosis.

How similar studies have gone: While there have been studies investigating immune cell roles in MS, this specific approach focusing on B and CD4 T cell subsets is novel and may provide new insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* male or female subjects ;
* Age ≥ 18 years;
* subjects with MS defined by 2010 revised McDonald criteria or presenting a clinical isolated syndrome;
* patients for which a blood draw and / or lumbar puncture to collect CSF is performed for diagnostic or therapeutic purpose;
* affiliated to an health insurance system;
* and who agree to participate in the study.

Exclusion Criteria:

* Pregnant or breastfeeding women,
* patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent)

Where it's running

  • CHU de Bordeaux - service de neurologie
    Bordeaux, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.